+91- 99099 19545
info@accuprec.com
FDA & EU MDR Biocompatibility Expectations Introduction Biocompatibility is a core requirement for medical device approvals across global markets. Among all regulatory authorities, the US Food and Drug Administration (FDA) and the European Union Medical Device Regulation (EU MDR) are...
Read More
Biological Evaluation Report (BER) Expectations Introduction The Biological Evaluation Report (BER) is one of the most critical documents in a medical device regulatory submission. While the Biological Evaluation Plan (BEP) explains what will be done, the BER demonstrates what was...
Read More
Biological Evaluation Plan (BEP) Explained Introduction A Biological Evaluation Plan (BEP) is one of the most important documents in the biocompatibility assessment of a medical device. Regulatory authorities such as the US FDA and EU Notified Bodies expect a clear,...
Read More
Impact of ISO 10993-1:2025 on Global Approvals Introduction Global approval of medical devices depends heavily on how well manufacturers demonstrate biocompatibility and patient safety. Regulatory authorities such as the US FDA, EU Notified Bodies and other international agencies rely on...
Read More
ISO 10993:2025 vs 2018 – Key Differences Introduction The ISO 10993 series is the global benchmark for evaluating the biocompatibility of medical devices. Among its parts, ISO 10993-1 plays a central role by defining the overall framework for biological evaluation....
Read More
What’s New in ISO 10993-1:2025 for Medical Devices Introduction Biocompatibility is a critical requirement for every medical device that comes in contact with the human body. Regulators across the world rely on the ISO 10993 series to evaluate whether a...
Read More
Accuprec Research Labs Pvt. Ltd. © 2026